Vericel (VCEL) Earnings Date, Estimates & Call Transcripts → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free VCEL Stock Alerts $48.10 -0.55 (-1.13%) (As of 05/10/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 7EstimatedActual EPS (May. 8) -$0.08 Beat By $0.03 Consensus EPS (May. 8) -$0.11 Read Call TranscriptListen to Call Get Vericel Earnings AlertsEnter your email address below to receive the latest news and earnings results for VCEL and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVCEL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VCEL Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… Vericel Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242($0.19)($0.10)($0.15) Q2 20242($0.15)($0.08)($0.12) Q3 20242($0.02)($0.01)($0.02) Q4 20242$0.31$0.39$0.35 FY 20248($0.05)$0.20$0.08 Q1 20252$0.03$0.04$0.04 Q2 20252$0.02$0.07$0.05 Q3 20252($0.02)$0.13$0.06 Q4 20252$0.30$0.45$0.38 FY 20258$0.33$0.69 $0.51VCEL Earnings Date and InformationVericel last issued its quarterly earnings results on May 8th, 2024. The biotechnology company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.03. The company earned $51.28 million during the quarter, compared to analysts' expectations of $49.07 million. Its revenue for the quarter was up 25.0% compared to the same quarter last year. Vericel has generated ($0.01) earnings per share over the last year (($0.01) diluted earnings per share). Earnings for Vericel are expected to grow by 390.00% in the coming year, from $0.10 to $0.49 per share. Vericel has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off prior year's report dates.Read More Vericel Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/7/2024Estimated)------- 5/8/2024Q1 2024($0.11)($0.08)+$0.03($0.08)$49.07 million$51.28 million 2/29/2024Q4 2023$0.18$0.26+$0.08$0.26$64.28 million$65.00 million 11/8/2023Q3 2023($0.13)($0.08)+$0.05($0.08)$45.14 million$45.58 million 8/2/2023Q2 2023($0.13)($0.11)+$0.02($0.11)$42.14 million$45.92 million 5/10/2023Q1 2023($0.13)($0.16)($0.03)($0.16)$38.45 million$41.02 million2/23/2023Q4 2022$0.02$0.12+$0.10$0.12$52.95 million$52.70 million Get the Latest News and Ratings for VCEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vericel and its competitors with MarketBeat's FREE daily newsletter. 11/9/2022Q3 2022($0.12)($0.14)($0.02)($0.14)$40.02 million$38.55 million8/3/2022Q2 2022($0.13)($0.19)($0.06)($0.19)$38.30 million$37.05 million5/4/2022Q1 2022($0.15)($0.15)-($0.15)$34.31 million$36.07 million 2/24/2022Q4 2021$0.17$0.09($0.08)$0.09$48.09 million$47.60 million 11/8/2021Q3 2021($0.03)($0.11)($0.08)($0.11)$38.07 million$34.51 million 8/3/2021Q2 2021($0.08)($0.08)-($0.08)$36.78 million$39.52 million Vericel Earnings - Frequently Asked Questions When is Vericel's earnings date? Vericel has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off last year's report dates. Learn more on VCEL's earnings history. Did Vericel beat their earnings estimates last quarter? In the previous quarter, Vericel (NASDAQ:VCEL) reported ($0.08) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.11) by $0.03. Learn more on analysts' earnings estimate vs. VCEL's actual earnings. How can I listen to Vericel's earnings conference call? The conference call for Vericel's latest earnings report can be listened to online. Listen to Conference Call How can I read Vericel's conference call transcript? The conference call transcript for Vericel's latest earnings report can be read online. Read Transcript How much revenue does Vericel generate each year? Vericel (NASDAQ:VCEL) has a recorded annual revenue of $197.52 million. How much profit does Vericel generate each year? Vericel (NASDAQ:VCEL) has a recorded net income of -$3.18 million. VCEL has generated -$0.01 earnings per share over the last four quarters. What is Vericel's EPS forecast for next year? Vericel's earnings are expected to grow from $0.10 per share to $0.49 per share in the next year, which is a 390.00% increase. More Earnings Resources from MarketBeat Related Companies: Denali Therapeutics Earnings Results Apogee Therapeutics Earnings Results Kymera Therapeutics Earnings Results Sana Biotechnology Earnings Results Ginkgo Bioworks Earnings Results Recursion Pharmaceuticals Earnings Results Fusion Pharmaceuticals Earnings Results Twist Bioscience Earnings Results Arcellx Earnings Results Beam Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:VCEL) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsCollapse of the Petrodollar Colonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe Exchange[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICMissed NVDA? Buy this AI stock NOWChaikin AnalyticsYou need to know these two things about AI stocks ASAP…InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vericel Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
